Your browser does not support java script. Skip navigation
Loading, please wait  Loading, please wait...
 

September UNC Health System Pharmacy Resident CE Series


Due to concerns about the novel coronavirus, and consistent with ongoing efforts to reduce spread of the virus, attendance for the September CE sessions will be WEBINAR ONLY.  Please see instructions below for registration.
 
PLEASE FOLLOW THE STEP-BY-STEP INSTRUCTIONS BELOW – DO NOT SKIP STEPS!
 
STEP 1:  REGISTER FOR THE CE CREDIT ON THIS SITE
** If you do not register for the CE at this link, you will not be able to access the evaluations to earn credit
** EVERYONE must register BEFORE the session date. NO NEW REGISTRATIONS WILL BE ADDED AFTER THE PROGRAM DATE
** you will receive an email confirming your registration at the email address provided – if you do not receive a confirmation email, try to register again
 
STEP 2:  AFTER SUCCESSFULLY REGISTERING - CLICK THE WEBEX LINK IN THE PROGRAM MODULE
** submit your contact information
** you will receive an email with instructions for joining the WebEx
 
STEP 3:  Collect the presenter code for each of the CEs that you attend
** EVERYONE will need the presenter codes to access evaluations and earn CE credit
 
STEP 4:  You will receive an automated email to log in and complete evaluations
** Evaluations must be completed within 60 days of the CE session
** You will need the presenter codes to access each evaluation
** Evaluations MUST be completed within 60 days of the program date to earn CE credit!
 
 

Date: Sep 1, 2020 05:00 PM - Sep 30, 2020 06:00 PM

CE Hours

6.00

CE Units

0.600

Registration closes on Sep 30, 2020 11:55 PM

Activity Type

  • Knowledge

Target Audience(s)

  • Pharmacists

Accreditation(s)

Participants have 60 days from the start of their program to claim CE credit and verify it has been upload to CPE Monitor. If your program requires the completion of a post test/eval/survey those items MUST be done before that 60 day window closes to receive credit for that program. Statements of credit can be viewed and printed from CPE Monitor. Statements of credit will no longer be printed and mailed to the participant. **No partial individual session credit will be given**
 
REGISTRATION NOTE: During the registration process, if a fee is required, please enter the zip code associated with your credit card's BILLING ADDRESS. For security purposes payments are processed through a separate system, so when prompted, please click “ok” to be taken to that site and complete your registration. Upon successful registration of this program you will receive an email confirmation/receipt and will be returned to this program page. When you are retuned to this page you will see a note at the top of the page reading “You are registered for this program.”
If you are not automatically returned to this page or see only a blank white screen your transaction was not successful, and you will need to try again.

 

If paying by check please mail to the address below:

UNC Eshelman School of Pharmacy
Attn: Continuing Education
301 Pharmacy Lane, CB# 7574 Beard Hall
Chapel Hill, NC 27599
 
 
Accreditation Council for Pharmacy Education
The University of North Carolina Eshelman School of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. To receive CE credit, participants must complete the CE attendance form and the online evaluation of the program (instructions to be emailed). Statements of credit can be viewed and printed in CPE Monitor approximately 2 to 3 weeks after the program and you have completed any needed requirements. **No partial credit will be available**

Co-Sponsor(s)

UNC Health System

Support/Credits

 
Cancelations: Cancelations must be received in writing/email to the Office of Continuing Education at least 48 hours prior to start date to receive a full refund. No refunds will be given within 48 hours of the start date.
 
 
IMPORTANT: UNC HEALTH SYSTEM EMPLOYEES AND UNC ESHELMAN SCHOOL OF PHARMACY STUDENTS ONLY
  1. UNC Health System Employees and UNC ESOP Students should register using your UNC email address. UNC Employees - please select your employment location during the registration process. UNC Students - please respond "Yes" to the "Are you a UNC Student" question.
  2. Select the “Check” payment method on the registration page. Your employment will be verified prior to credit being uploaded.

 

 

Registration closes on Sep 30, 2020 at 11:55 PM

Registration Closed  

Program to be held from 1p-2p, then repeated from 2p-3p
 
Meeting number (access code): 160 065 0794   
Meeting password: ZFhBJGHg266
 
Meeting number (access code): 160 300 2492
Meeting password: sGQ4gNsG2G3

Objectives

  • Recall the pathophysiology of COVID-19 and ARDS
  • Discuss the current literature regarding steroids and ARDS
  • Examine the role of steroids for COVID-19 treatment
  • Summarize treatment recommendations in COVID-19 with ARDS

Speaker(s)/Author(s)

Sheniece Carpenter, PharmD, MSCR
PGY1 Pharmacy Resident, UNC REX

Activity Number

0046-9999-20-260-L01-P/T
Date: 09/02/20
Time: 01:00 PM - 03:00 PM

CE Hours

1.00

Location

Online
Registration Closed  

Registration closes on Sep 30, 2020 at 11:55 PM

Registration Closed  

 
Presentation Slides availble for download at the bottom of this module. You MUST be signed into your registered account to access this content.

Objectives

  • Review the pharmacology and pharmacokinetics of mTOR inhibitors.
  • Explain the antiviral properties and utility of mTOR inhibitors in the development of viral infections in solid organ transplant (SOT) recipients.
  • 3Discuss the antiproliferative properties and role of mTOR inhibitors in cardiac allograft vasculopathy.
  • Describe the antitumor properties and use of mTOR inhibitors in SOT recipients with malignancies.
  • Outline a plan for safely initiating mTOR inhibitors in SOT recipients.

Speaker(s)/Author(s)

Krysta Walter, PharmD
PGY2 Pharmacy Resident Transplant

Activity Number

0046-9999-20-249-L01-P
Date: 09/03/20
Time: 05:00 PM - 06:00 PM

CE Hours

1.00

Location

Online
Registration Closed  

Registration closes on Sep 30, 2020 at 11:55 PM

Registration Closed  

 
Presentation Slides availble for download at the bottom of this module. You MUST be signed into your registered account to access this content.

Objectives

  • At the completion of this activity, the participant will be able to: Review the fundamental indications, prevalence, prognosis, complications, and types of circuits associated with patients on ECMO
  • Examine common pharmacokinetic and pharmacodynamic alterations for patients on ECMO based on patient-, drug-, and circuit-specific factors
  • Develop an analgesia and sedation plan for patients on ECMO based on existing literature
  • Assess the relevance of antithrombin III monitoring and administration in the management of heparin resistance

Speaker(s)/Author(s)

Zach Pedretti, PharmD
PGY-1 Pharmacy Resident

Activity Number

0046-9999-20-271-L01-P
Date: 09/10/20
Time: 05:00 PM - 06:00 PM

CE Hours

1.00

Location

Online
Registration Closed  

Registration closes on Sep 30, 2020 at 11:55 PM

Registration Closed  

 
Meeting ID: 160 485 2704
 
Presentation Slides availble for download at the bottom of this module. You MUST be signed into your registered account to access this content.

Objectives

  • Discuss the prevalence and clinical presentation of Cannabinoid Hyperemesis Syndrome (CHS)
  • Summarize proposed mechanisms of CHS pathophysiology
  • Outline current treatment options for CHS
  • Recognize economic consequences of delayed diagnosis

Speaker(s)/Author(s)

Emily Witcraft, PharmD
PGY1 Pharmacotherapy Resident

Activity Number

046-9999-20-278-L01-P
Date: 09/17/20
Time: 05:00 PM - 06:00 PM

CE Hours

1.00

Location

Online
Registration Closed  

Registration closes on Sep 30, 2020 at 11:55 PM

Registration Closed  

Program to be held from 1p-2p, then repeated from 2p-3p
 
Meeting number (access code): 172 485 9180
 
Meeting password: 3tJUPJrmG24
 
Session 2 (1400- 1500) -https://unchealth.webex.com/unchealth/j.php?MTID=m04fc39d5aebb21e54dc7432aa51208e3
Meeting number (access code): 172 945 6795
 
Meeting password: ngVnAnqn394
 
Presentation Slides availble for download at the bottom of this module. You MUST be signed into your registered account to access this content.

Objectives

  • Define pediatric cystic fibrosis (CF)
  • Define the pathophysiology of CF
  • Review roles of genetics in CF
  • Discuss existing and new treatment options for pediatric CF
  • Identify future CFTR modulator treatment options for pediatric CF

Speaker(s)/Author(s)

Tyler Brouse, PharmD
PGY1 Pharmacy Practice Resident, UNC REX Healthcare

Activity Number

0046-9999-20-279-L01-P/T
Date: 09/24/20
Time: 01:00 PM - 03:00 PM

CE Hours

1.00

Location

Online
Registration Closed  

Registration Closed  

Meeting: 160 490 9092
Password: UNCPharm1
 
Presentation Slides availble for download at the bottom of this module. You MUST be signed into your registered account to access this content.

Objectives

  • Outline evidence-based strategies to reduce the risk of antipsychotic-induced TD
  • Analyze literature to conceptualize the comparative efficacy of treatment options for TD
  • Describe a treatment algorithm for the management of TD based on the cost-effectiveness of treatment options for TD

Speaker(s)/Author(s)

Frank Tillman III, PGY1 Pharmacy Practice Resident
PharmD

Activity Number

0046-9999-20-250-L01-P
Date: 09/24/20
Time: 05:00 PM - 05:30 PM

CE Hours

0.50

Location

Online
Registration Closed  

Registration Closed  

Meeting: 160 490 9092
Password: UNCPharm1
 
Presentation Slides availble for download at the bottom of this module. You MUST be signed into your registered account to access this content.

Objectives

  • Describe the current treatment modalities for obsessive compulsive disorder (OCD) and their place in therapy
  • Discuss if the clinical efficacy of selective serotonin reuptake inhibitors for OCD can be attributed more to a class effect or a dose response relationship
  • Discuss if the use clomipramine and fluvoxamine for OCD treatment is justified based on pharmacokinetic parameters and clinical response

Speaker(s)/Author(s)

Joshua Knebel

Activity Number

0046-9999-20-251-L01-P
Date: 09/24/20
Time: 05:30 PM - 06:00 PM

CE Hours

0.50

Location

Online
Registration Closed